BeStock  
Stocks › Medical Devices › CNMD

ConMed CNMD

US equityMarket cap rank #2930Medical Devices
$46.56 +$0.18 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.56 0.00%
Open$46.11
Prev close$46.38
Day range$45.94 – $48.00
Volume384.3K
Market cap$1.39B
P/E (TTM)19.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership112.0%-2.51 pts vs. prior quarter
Institutions holding315+8 vs. prior quarter
Insider trades (recent)38 buys / 6 sellsNet buying
Short interest6.24% of floatDays to cover 4.3 · as of 30 Oct 2026
Short-sale volume share21.3%5-day average of daily volume

Short-sale volume as % of daily volume

17%24%31%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.82M (15 inflow days, 5 outflow days).

Net flow by order size, last 20 sessions

+$203.5KSuper+$2.6MBig−$1.9MMid−$2.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 42.5% of shares outstanding.

Largest holders

  • BlackRock16.56%
  • EARNEST Partners, LLC8.32%
  • Vanguard Portfolio Management, LLC7.42%
  • Fuller & Thaler Asset Management, Inc.5.30%
  • Dimensional Fund Advisors4.95%
  • State Street Global Advisors4.69%
  • Vanguard Capital Management, LLC4.45%
  • Managed Account Advisors LLC3.80%

By investor type

  • Mutual Fund98.52%
  • Hedge Fund7.06%
  • Public Company3.92%
  • Government Pension Fund1.45%
  • Individual/Insider0.91%
  • Private Company0.50%
  • Insurance Company0.37%
  • Government0.10%

Reported short interest has fallen from 7.74% to 6.24% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Dimensional Fund Advisors Mutual Fund 2026/Q3 +156,588 4.9%
BlackRock Mutual Fund 2026/Q3 +114,588 16.6%
Morgan Stanley Public Company 2026/Q3 +88,884 1.1%
Citigroup Inc. Public Company 2026/Q3 +79,618 0.3%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +78,943 0.6%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +62,199 0.6%
Franklin Resources Mutual Fund 2026/Q3 +55,634 0.2%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +50,964 0.3%
Exchange Traded Concepts, LLC Mutual Fund 2026/Q3 +32,330 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +64,055 0.2%
Paradigm Capital Management, Inc. Mutual Fund 2026/Q3 +538,245 1.8%
LSV Asset Management Mutual Fund 2026/Q3 +389,400 1.3%
AQR Capital Management Hedge Fund 2026/Q3 +199,444 0.9%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +164,126 0.9%
Victory Capital Management Inc. Mutual Fund 2026/Q3 +161,639 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
3 Nov 2026 Hollie Foust General Counsel Derivative Exercise and Sale -1,124 $53.66 5,762
3 Nov 2026 Hollie Foust General Counsel Derivative Exercise and Retained +2,876 – 5,762
7 Sep 2026 Kim Kelderman Director Derivative Exercise and Retained +500 – 500
14 Jul 2026 John Gallagher Executive VP, CFO and Principal Financial & Accounting Officer Other Derivative Acquisition +30,536 $42.79 30,536
14 Jul 2026 John Gallagher Executive VP, CFO and Principal Financial & Accounting Officer Other Derivative Acquisition +61,929 – 61,929
14 Jul 2026 John Gallagher Executive VP, CFO and Principal Financial & Accounting Officer Initial Statement of Beneficial +0 – –
30 Jun 2026 Jeffrey Mirviss Director Other Derivative Acquisition +5,603 – 5,603
30 Jun 2026 Jeffrey Mirviss Director Initial Statement of Beneficial +0 – –
30 Jun 2026 Celine Martin Director Other Derivative Acquisition +5,603 – 5,603
30 Jun 2026 Celine Martin Director Initial Statement of Beneficial +0 – –
1 Jun 2026 David Bronson Independent Director Derivative Exercise and Retained +668 – 17,909
1 Jun 2026 Laverne Council Independent Chairperson Derivative Exercise and Retained +668 – 4,716
1 Jun 2026 Mark Kaye Independent Director Derivative Exercise and Retained +668 – 820
1 Jun 2026 Charles Farkas Independent Director Derivative Exercise and Retained +668 – 15,527
1 Jun 2026 Barbara Schwarzentraub Independent Director Derivative Exercise and Retained +668 – 6,454
31 May 2026 David Bronson Independent Director Other Derivative Acquisition +5,772 – 5,772
31 May 2026 Kim Kelderman Director Other Derivative Acquisition +5,772 – 5,772
31 May 2026 Laverne Council Independent Chairperson Other Derivative Acquisition +5,772 – 5,772
31 May 2026 Mark Kaye Independent Director Other Derivative Acquisition +5,772 – 5,772
31 May 2026 Charles Farkas Independent Director Other Derivative Acquisition +5,772 – 5,772

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 1,861,112 6.2% 4.3
15 Oct 2026 1,912,120 6.4% 4.7
30 Sep 2026 1,955,193 6.5% 5.2
15 Sep 2026 2,137,300 7.1% 7.3
31 Aug 2026 2,264,209 7.6% 7.2
14 Aug 2026 2,319,480 7.7% 5.0

Discussion

No comments yet — be the first to weigh in on CNMD.

Sign in to join the discussion.

Scroll to Top